Entry - #301900 - BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS - OMIM
# 301900

BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS


Alternative titles; symbols

MENTAL RETARDATION, X-LINKED, SYNDROMIC, BORJESON-FORSSMAN-LEHMANN TYPE; MRXSBFL
BORJESON SYNDROME; BORJ
MENTAL RETARDATION, EPILEPSY, AND ENDOCRINE DISORDERS


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
Xq26.2 Borjeson-Forssman-Lehmann syndrome 301900 XLR 3 PHF6 300414
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- X-linked recessive
GROWTH
Height
- Short stature
Weight
- Moderate obesity
HEAD & NECK
Head
- Microcephaly
Face
- Coarse facies
- Prominent supraorbital ridges
Ears
- Large ears
Eyes
- Deep-set eyes
- Nystagmus
- Ptosis
- Poor vision
- Narrow palpebral fissures
CHEST
Breasts
- Gynecomastia, postpubertal
GENITOURINARY
External Genitalia (Male)
- Small penis
Internal Genitalia (Male)
- Small, atrophic testes
- Cryptorchidism
- Hypoplastic prostate
SKELETAL
Skull
- Thick calvarium
Spine
- Narrow cervical spinal canal
- Mild scoliosis
- Kyphosis
- Scheuermann-like vertebral changes
Hands
- Hypoplastic distal and middle phalanges
- Soft, fleshy hands
- Tapering fingers
Feet
- Short toes
- Widely spaced and flexed toes
NEUROLOGIC
Central Nervous System
- Severe mental retardation (IQ 10-40)
- Hypotonia
- Abnormal EEG (poor alpha rhythms)
- Seizures
ENDOCRINE FEATURES
- Delayed puberty
MISCELLANEOUS
- Majority of female carriers have skewed X-inactivation (inactivation of chromosome containing the PHF6 (300414) mutation)
- Some female heterozygotes express phenotypic features (e.g., coarse facies, mild mental retardation)
MOLECULAR BASIS
- Caused by mutation in the PHD finger protein 6 gene (PHF6, 300414.0001)
Intellectual developmental disorder, X-linked syndromic - PS309510 - 56 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
Xp22.2 Raynaud-Claes syndrome XLD 3 300114 CLCN4 302910
Xp22.2 Basilicata-Akhtar syndrome XLD 3 301032 MSL3 300609
Xp22.2 Intellectual developmental disorder, X-linked syndromic, Pilorge type XL 3 301076 GLRA2 305990
Xp22.2 Pettigrew syndrome XLR 3 304340 AP1S2 300629
Xp22.12 Intellectual developmental disorder, X-linked syndromic, Houge type XL 3 301008 CNKSR2 300724
Xp22.11 Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type XLR 3 309583 SMS 300105
Xp22.11 MEHMO syndrome XLR 3 300148 EIF2S3 300161
Xp22.11 Intellectual developmental disorder, X-linked syndromic 37 XL 3 301118 ZFX 314980
Xp22.11-p21.3 Van Esch-O'Driscoll syndrome XLR 3 301030 POLA1 312040
Xp21.3 Partington syndrome XLR 3 309510 ARX 300382
Xp21.1-p11.23 Intellectual developmental disorder, X-linked syndromic 17 XLR 2 300858 MRXS17 300858
Xp11 ?Intellectual developmental disorder, X-linked syndromic 12 XL 2 309545 MRXS12 309545
Xp11.4 Intellectual developmental disorder, X-linked syndromic, Hedera type XLR 3 300423 ATP6AP2 300556
Xp11.4 Intellectual developmental disorder, X-linked syndromic, Snijders Blok type XLD, XLR 3 300958 DDX3X 300160
Xp11.4 Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia XL 3 300749 CASK 300172
Xp11.3-q22 Intellectual developmental disorder, X-linked syndromic 7 XL 2 300218 MRXS7 300218
Xp11.2 Intellectual developmental disorder, X-linked, syndromic, Stocco dos Santos type XL 2 300434 SDSX 300434
Xp11.23 Renpenning syndrome XLR 3 309500 PQBP1 300463
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type XLR 3 300534 KDM5C 314690
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Turner type XL 3 309590 HUWE1 300697
Xp11.22 Intellectual developmental disorder, X-linked syndromic, Siderius type XLR 3 300263 PHF8 300560
Xp11.22 Prieto syndrome XLR 3 309610 WNK3 300358
Xp11.22 Aarskog-Scott syndrome XLR 3 305400 FGD1 300546
Xp11.22 Intellectual developmental disorder, X-linked syndromic 16 XLR 3 305400 FGD1 300546
Xq11.2 Wieacker-Wolff syndrome XLR 3 314580 ZC4H2 300897
Xq12-q21.31 Intellectual developmental disorder, X-linked syndromic 9 2 300709 MRXS9 300709
Xq12 Wilson-Turner syndrome XLR 3 309585 LAS1L 300964
Xq12 Intellectual developmental disorder, X-linked syndromic, Billuart type XLR 3 300486 OPHN1 300127
Xq13-q21 Martin-Probst syndrome XLR 2 300519 MRXSMP 300519
Xq13.1 ?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia XLR 3 300472 IGBP1 300139
Xq13.1 Lujan-Fryns syndrome XLR 3 309520 MED12 300188
Xq13.1 Intellectual developmental disorder, X-linked syndromic 34 XL 3 300967 NONO 300084
Xq13.1 Intellectual developmental disorder, X-linked syndromic 33 XLR 3 300966 TAF1 313650
Xq13.2 Intellectual developmental disorder, X-linked syndromic, Abidi type XL 2 300262 MRXSAB 300262
Xq13.2 Tonne-Kalscheuer syndrome XL 3 300978 RLIM 300379
Xq21.33-q23 Intellectual developmental disorder, X-linked syndromic, Chudley-Schwartz type XLR 2 300861 MRXSCS 300861
Xq22.1 Intellectual developmental disorder, X-linked syndromic, Bain type XLD 3 300986 HNRNPH2 300610
Xq22.3 Arts syndrome XLR 3 301835 PRPS1 311850
Xq24 Intellectual developmental disorder, X-linked syndromic, Nascimento type XLR 3 300860 UBE2A 312180
Xq24 Intellectual developmental disorder, X-linked syndromic 14 XLR 3 300676 UPF3B 300298
Xq24 Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type XLR 3 301039 NKAP 300766
Xq24 Intellectual developmental disorder, X-linked syndromic, Cabezas type XLR 3 300354 CUL4B 300304
Xq25 Intellectual developmental disorder, X-linked syndromic, Wu type XLR 3 300699 GRIA3 305915
Xq26.1 Intellectual developmental disorder, X-linked syndromic, Raymond type XL 3 300799 ZDHHC9 300646
Xq26.2 ?Paganini-Miozzo syndrome XLR 3 301025 HS6ST2 300545
Xq26.2 Borjeson-Forssman-Lehmann syndrome XLR 3 301900 PHF6 300414
Xq26.3 Intellectual developmental disorder, X-linked syndromic, Christianson type XL 3 300243 SLC9A6 300231
Xq26.3 ?Intellectual developmental disorder, X-linked syndromic, Shashi type XLR 3 300238 RBMX 300199
Xq26.3 ?Intellectual developmental disorder, X-linked syndromic, Gustavson type XLR 3 309555 RBMX 300199
Xq27.3 Fragile X syndrome XLD 3 300624 FMR1 309550
Xq28 Intellectual developmental disorder, X-linked 109 XLR 3 309548 AFF2 300806
Xq28 Intellectual developmental disorder, X-linked syndromic 13 XLR 3 300055 MECP2 300005
Xq28 Intellectual developmental disorder, X-linked syndromic, Lubs type XLR 3 300260 MECP2 300005
Xq28 Intellectual developmental disorder, X-linked syndromic 35 XLR 3 300998 RPL10 312173
Xq28 Intellectual developmental disorder, X-linked syndromic, Armfield type XLR 3 300261 FAM50A 300453
Xq28 ?Intellectual developmental disorder, X-linked syndromic 32 XLR 3 300886 CLIC2 300138

TEXT

A number sign (#) is used with this entry because of evidence that Borjeson-Forssman-Lehmann syndrome (BFLS) is caused by mutation in the PHF6 gene (300414) on chromosome Xq26.


Description

Borjeson-Forssman-Lehmann syndrome (BFLS) is an uncommon X-linked intellectual developmental disorder that evolves with age. Clinical manifestations in males are quite variable, with the most consistent features being initial hypotonia, mild to moderate impaired intellectual development, large fleshy ears, underdeveloped genitalia, gynecomastia, truncal obesity, tapering fingers, and shortening of the fourth and fifth toes. Heterozygous females may have a milder similar clinical phenotype, which can include hypothyroidism; however, many carrier females appear unaffected (summary by Crawford et al., 2006).


Clinical Features

The features of this syndrome in the single kindred described by Borjeson et al. (1962) were severe mental defect, epilepsy, hypogonadism, hypometabolism, marked obesity, swelling of subcutaneous tissue of face, narrow palpebral fissure, and large but not deformed ears. Three females who might be carriers had moderate mental retardation. Brun et al. (1974) extended the observations of Borjeson et al. (1962). Baar and Galindo (1965) described a single case they thought represented the same entity. Robinson et al. (1983) observed a Saudi Arabian sibship with a severely affected male and a more mildly affected pair of female monozygotic twins. They pointed to a report of cases by Weber et al. (1978) as well as others.

Ardinger et al. (1984) studied 5 affected males in 2 unrelated families. The authors were impressed with a characteristic facial appearance which included prominent superciliary ridges, deep-set eyes, ptosis, and large ears. They could find no reliable means of identifying heterozygotes. The differential diagnosis includes Prader-Willi (176270), Coffin-Lowry (303600), and Bardet-Biedl (209900) syndromes.

Turner et al. (2004) reviewed the clinical features of affected males in 9 families with BFLS in which mutation in the PHF6 gene had been identified (Lower et al., 2002). The clinical history and physical findings in the affected males indicated that the phenotype is milder and more variable than previously described and evolves with age. Generally, in the first year, the babies are floppy, with failure to thrive, big ears, and small external genitalia. As schoolboys, the picture is one of learning problems and moderate short stature, with emerging truncal obesity and gynecomastia. Head circumferences are usually normal, and macrocephaly may be seen. Big ears and small genitalia remain. The toes are short and fingers tapered and malleable. In late adolescence and adult life, the classically described heavy facial appearance emerges. Some heterozygous females showed milder clinical features such as tapering fingers and shortened toes. Significant learning problems were found in 20%, and skewed X inactivation in 95%. Turner et al. (2004) concluded that the syndrome may be underdiagnosed in males in their early years and missed altogether in isolated heterozygous females.

Manifestations in Females

Dereymaeker et al. (1986) described a typical case. The mother had suggestive features, and a first cousin, the daughter of a maternal male (who was himself 'feeble-minded,' but with a normal somatic phenotype), had hyperkyphosis that increased with age, no menarche at age 17, and sudden death at age 17 due probably to epileptic seizures.

Using a methylation-specific PCR assay, Kubota et al. (1999) demonstrated that a woman with typical findings of the BFL syndrome had an extremely skewed X-inactivation pattern. The 32-year-old Japanese woman was the only affected member of her family. She was hypotonic during early infancy and attended a school for the mentally handicapped. She had the first seizure at age 3 and became obese at age 5. Diabetic ketoacidosis crisis occurred at age 31 years. Her height was only 142 cm. She had a 'coarse' face with a narrow forehead, prominent supraorbital ridges, narrow palpebral fissures, ptosis, deep-set eyes, full cheeks, and large ears. Her hands were small with tapering fingers and short fifth fingers.

In all but 1 of the female carriers tested by Lower et al. (2002), the chromosome carrying the mutation in PHF6 (300414; see later) was 100% inactivated. The exception was a woman with roughly 70% skewing, who showed mild clinical features of BFLS, including obesity, large ears, amenorrhea, hypothyroidism, epilepsy, and learning difficulties.

Crawford et al. (2006) reported a 14-year-old girl with BFLS-like symptoms, with psychomotor retardation, IQ of 84 at age 4, and a remarkably shallow forehead, large ears with fleshy earlobes, deep-set eyes with a wide neck and face, broad feet, and hammertoes. Testing of her blood DNA showed a 93% skewed X-inactivation pattern.

Wieczorek et al. (2013) reported 2 females described as having Coffin-Siris syndrome (CSS; 135900) with mutations in the PHF6 gene. The first girl presented with mild to moderate developmental delay, hypertrichosis, coarse facial features, hypoplastic fifth finger- and toenails, and hypoplastic fifth digits. These features fulfilled the diagnostic criteria for CSS; Wieczorek et al. (2013) remarked that more characteristic clinical features of BFLS may not be evident in early childhood. A second girl was found to have a de novo frameshift mutation in PHF6. She had mild intellectual disability, average stature, and hypoplasia of distal phalanges of the fifth digits. Additionally, she had nystagmus, strabismus, and coarse facial features.


Mapping

In a family with presumed BFL syndrome, Mulley et al. (1989) found suggestions of linkage to X DNA markers that would place the locus in the Xq26-q27 region. On the basis of the same study, Turner et al. (1989) reported a maximum lod score of 2.1 at theta = 0.0 with DXS51. The regional localization was thought to be Xq26-q27. The 7 affected males showed mild to moderate intellectual handicap, remarkably long, thick ears, deep-set eyes, small testes, and postpubertal gynecomastia. The affected males and some of the heterozygous females also had tapering fingers and short, widely spaced and flexed toes. Mathews et al. (1989) also found evidence suggesting location of the BFLS locus on distal Xq. They found maximum lod scores of 2.32 with DXS10 and 2.24 with DXS51, both at theta = 0.0. Mathews et al. (1989) combined the 2 sets of data and arrived at a maximum lod score of 4.09. The family studied by Mathews et al. (1989) was one of those reported by Ardinger et al. (1984). The clinical features as demonstrated by the photographs were strikingly similar to those in the family of Turner et al. (1989).


Molecular Genetics

Lower et al. (2002) narrowed the interval of the BFLS locus to roughly 9 Mb containing more than 62 genes. Among these, a novel, widely expressed zinc finger gene, designated PHF6 (300414), had 8 missense and truncation mutations in 7 familial and 2 sporadic cases of BFLS. Transfection studies with PHF6 tagged with green fluorescent protein (GFP) showed diffuse nuclear staining with prominent nucleolar accumulation. Such localization, and the presence of 2 plant homeodomain (PHD)-like zinc fingers, suggested a role for PHF6 in transcription.

Lower et al. (2004) identified a mutation in the PHF6 gene (300414.0001) in affected members of the original BFLS family reported by Borjeson et al. (1962) and in affected members of a previously undescribed BFLS family from Western Australia.

In a 14-year-old girl with BFLS-like symptoms, Crawford et al. (2006) identified heterozygosity for a 1-bp insertion in the PHF6 gene (300414.0010). The authors stated that this was the first report of a clinically diagnosed BFLS female with a confirmed PHF6 mutation. Crawford et al. (2006) also identified mutations in the PHF6 gene in 4 of 24 unrelated males with clinically diagnosed BFLS; 1 was an isolated case with skewed maternal X inactivation, and 3 were familial cases, of which 2 had skewed maternal X inactivation. Crawford et al. (2006) concluded that the success of PHF6 screening in males suspected of having BFLS is markedly increased if there is a positive family history and/or skewed X inactivation is found in the mother.

Gecz et al. (2006) reviewed the clinical features and molecular genetics of BFLS, stating that 19 unrelated mutation-positive cases had been reported, of which 13 were familial and 6 were isolated cases.

Wieczorek et al. (2013) reported 2 females, each with a de novo mutation in the PHF6 gene (e.g., C305F; 300414.0011), who fulfilled diagnostic criteria for Coffin-Siris syndrome (CSS; 135900).


History

Gecz et al. (1999) identified a male infant with BFLS-like features and a duplication, 46,Y,dup(X)(q26q28), inherited from his phenotypically normal mother. FISH using yeast artificial chromosome clones from Xq26 localized the duplication breakpoint to an interval of approximately 400 kb in the Xq26.3 region between DXS155 and DXS294/DXS730. Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor-13 gene (FGF13; 300070) within the duplication breakpoint interval. Northern blot hybridization showed highest expression of FGF13 in brain and skeletal muscle. The FGF13 gene localization and tissue-specific expression pattern suggested that it is a candidate gene for familial cases of BFLS and other syndromal and nonspecific forms of X-linked mental retardation mapping to that region.


REFERENCES

  1. Ardinger, H. H., Hanson, J. W., Zellweger, H. U. Borjeson-Forssman-Lehmann syndrome: further delineation in five cases. Am. J. Med. Genet. 19: 653-664, 1984. [PubMed: 6517094, related citations] [Full Text]

  2. Baar, H. S., Galindo, J. The Borjeson-Forssman-Lehmann syndrome. J. Ment. Defic. Res. 9: 125-130, 1965. [PubMed: 14323171, related citations] [Full Text]

  3. Borjeson, M., Forssman, H., Lehmann, O. An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med. Scand. 171: 13-21, 1962. [PubMed: 13871358, related citations] [Full Text]

  4. Brun, A., Borjeson, M., Forssman, H. An inherited syndrome with mental deficiency and endocrine disorder: a patho-anatomical study. J. Ment. Defic. Res. 18: 317-325, 1974. [PubMed: 4465467, related citations] [Full Text]

  5. Crawford, J., Lower, K. M., Hennekam, R. C. M., Van Esch, H., Megarbane, A., Lynch, S. A., Turner, G., Gecz, J. Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J. Med. Genet. 43: 238-243, 2006. [PubMed: 15994862, images, related citations] [Full Text]

  6. Dereymaeker, A. M., Fryns, J. P., Hoefnagels, M., Heremans, G., Marien, J., van den Berghe, H. The Borjeson-Forssman-Lehmann syndrome: a family study. Clin. Genet. 29: 317-320, 1986. [PubMed: 3720009, related citations]

  7. Flannery, D. B., Piussan, C., Wright, L. E. Dermatoglyphics in Borjeson-Forssman-Lehmann syndrome. (Letter) Am. J. Med. Genet. 21: 401-404, 1985. [PubMed: 4014320, related citations] [Full Text]

  8. Gecz, J., Baker, E., Donnelly, A., Ming, J. E., McDonald-McGinn, D. M., Spinner, N. B., Zackai, E. H., Sutherland, G. R., Mulley, J. C. Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum. Genet. 104: 56-63, 1999. [PubMed: 10071193, related citations] [Full Text]

  9. Gecz, J., Turner, G., Nelson, J., Partington, M. The Borjeson-Forssman-Lehman (sic) syndrome (BFLS, MIM #301900). Europ. J. Hum. Genet. 14: 1233-1237, 2006. [PubMed: 16912705, related citations] [Full Text]

  10. Kubota, T., Oga, S., Ohashi, H., Iwamoto, Y., Fukushima, Y. Borjeson-Forssman-Lehmann syndrome in a woman with skewed X-chromosome inactivation. Am. J. Med. Genet. 87: 258-261, 1999. [PubMed: 10564881, related citations]

  11. Lower, K. M., Solders, G., Bondeson, M.-L., Nelson, J., Brun, A., Crawford, J., Malm, G., Borjeson, M., Turner, G., Partington, M., Gecz, J. 1024C-T (R342X) is a recurrent PHF6 mutation also found in the original Borjeson-Forssman-Lehmann syndrome family. (Letter) Europ. J. Hum. Genet. 12: 787-789, 2004. [PubMed: 15241480, related citations] [Full Text]

  12. Lower, K. M., Turner, G., Kerr, B. A., Mathews, K. D., Shaw, M. A., Gedeon, A. K., Schelley, S., Hoyme, H. E., White, S. M., Delatycki, M. B., Lampe, A. K., Clayton-Smith, J., and 9 others. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nature Genet. 32: 661-665, 2002. [PubMed: 12415272, related citations] [Full Text]

  13. Mathews, K. D., Ardinger, H. H., Nishimura, D. Y., Buetow, K. H., Murray, J. C., Bartley, J. A. Linkage localization of Borjeson-Forssman-Lehmann syndrome. Am. J. Med. Genet. 34: 470-474, 1989. [PubMed: 2624254, related citations] [Full Text]

  14. Mathews, K. D., Buetow, K., Turner, G., Mulley, J. Borjeson-Forssman-Lehmann syndrome localization. (Letter) Am. J. Med. Genet. 34: 475 only, 1989. [PubMed: 2491427, related citations] [Full Text]

  15. Mulley, J. C., Turner, G., Gedeon, A., Sutherland, G. R., Rae, J., Power, K., Arthur, I. Borjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. (Abstract) Cytogenet. Cell Genet. 51: 1049 only, 1989.

  16. Robinson, L. K., Jones, K. L., Culler, F., Nyhan, W. L., Sakati, N., Jones, K. L. The Borjeson-Forssman-Lehmann syndrome. Am. J. Med. Genet. 15: 457-468, 1983. [PubMed: 6683929, related citations] [Full Text]

  17. Turner, G., Gedeon, A., Mulley, J., Sutherland, G., Rae, J., Power, K., Arthur, I. Borjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. Am. J. Med. Genet. 34: 463-469, 1989. [PubMed: 2624253, related citations] [Full Text]

  18. Turner, G., Lower, K. M., White, S. M., Delatycki, M., Lampe, A. K., Wright, M., Clayton-Smith, J., Kerr, B., Schelley, S., Hoyme, H. E., De Vries, B. B. A., Kleefstra, T., Grompe, M., Cox, B., Gecz, J., Partington, M. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin. Genet. 65: 226-232, 2004. [PubMed: 14756673, related citations] [Full Text]

  19. Weber, F. T., Frias, J. L., Julius, R. L., Felman, A. H. Primary hypogonadism in the Borjeson-Forssman-Lehmann syndrome. J. Med. Genet. 15: 63-66, 1978. [PubMed: 564968, related citations] [Full Text]

  20. Wieczorek, D., Bogershausen, N., Beleggia, F., Steiner-Haldenstatt, S., Pohl, E., Li, Y., Milz, E., Martin, M., Thiele, H., Altmuller, J., Alanay, Y., Kayserili, H., and 44 others. A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum. Molec. Genet. 22: 5121-5135, 2013. [PubMed: 23906836, related citations] [Full Text]


Ada Hamosh - updated : 06/27/2014
Marla J. F. O'Neill - updated : 3/2/2007
Marla J. F. O'Neill - updated : 4/19/2006
Marla J. F. O'Neill - updated : 11/5/2004
Victor A. McKusick - updated : 2/25/2004
Victor A. McKusick - updated : 11/4/2002
Victor A. McKusick - updated : 12/6/1999
Victor A. McKusick - updated : 3/16/1999
Creation Date:
Victor A. McKusick : 6/4/1986
carol : 03/01/2021
carol : 02/18/2021
carol : 03/12/2020
alopez : 06/27/2014
carol : 10/26/2011
ckniffin : 10/25/2011
wwang : 3/6/2007
terry : 3/2/2007
wwang : 4/20/2006
terry : 4/19/2006
tkritzer : 11/5/2004
tkritzer : 3/1/2004
terry : 2/25/2004
alopez : 12/3/2002
alopez : 11/5/2002
terry : 11/4/2002
carol : 12/22/1999
carol : 12/8/1999
terry : 12/6/1999
terry : 5/20/1999
carol : 3/17/1999
terry : 3/16/1999
mimadm : 2/27/1994
carol : 2/25/1994
supermim : 3/17/1992
supermim : 3/20/1990
supermim : 2/6/1990
carol : 12/14/1989

# 301900

BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS


Alternative titles; symbols

MENTAL RETARDATION, X-LINKED, SYNDROMIC, BORJESON-FORSSMAN-LEHMANN TYPE; MRXSBFL
BORJESON SYNDROME; BORJ
MENTAL RETARDATION, EPILEPSY, AND ENDOCRINE DISORDERS


SNOMEDCT: 21634003;   ORPHA: 127;   DO: 0050681;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
Xq26.2 Borjeson-Forssman-Lehmann syndrome 301900 X-linked recessive 3 PHF6 300414

TEXT

A number sign (#) is used with this entry because of evidence that Borjeson-Forssman-Lehmann syndrome (BFLS) is caused by mutation in the PHF6 gene (300414) on chromosome Xq26.


Description

Borjeson-Forssman-Lehmann syndrome (BFLS) is an uncommon X-linked intellectual developmental disorder that evolves with age. Clinical manifestations in males are quite variable, with the most consistent features being initial hypotonia, mild to moderate impaired intellectual development, large fleshy ears, underdeveloped genitalia, gynecomastia, truncal obesity, tapering fingers, and shortening of the fourth and fifth toes. Heterozygous females may have a milder similar clinical phenotype, which can include hypothyroidism; however, many carrier females appear unaffected (summary by Crawford et al., 2006).


Clinical Features

The features of this syndrome in the single kindred described by Borjeson et al. (1962) were severe mental defect, epilepsy, hypogonadism, hypometabolism, marked obesity, swelling of subcutaneous tissue of face, narrow palpebral fissure, and large but not deformed ears. Three females who might be carriers had moderate mental retardation. Brun et al. (1974) extended the observations of Borjeson et al. (1962). Baar and Galindo (1965) described a single case they thought represented the same entity. Robinson et al. (1983) observed a Saudi Arabian sibship with a severely affected male and a more mildly affected pair of female monozygotic twins. They pointed to a report of cases by Weber et al. (1978) as well as others.

Ardinger et al. (1984) studied 5 affected males in 2 unrelated families. The authors were impressed with a characteristic facial appearance which included prominent superciliary ridges, deep-set eyes, ptosis, and large ears. They could find no reliable means of identifying heterozygotes. The differential diagnosis includes Prader-Willi (176270), Coffin-Lowry (303600), and Bardet-Biedl (209900) syndromes.

Turner et al. (2004) reviewed the clinical features of affected males in 9 families with BFLS in which mutation in the PHF6 gene had been identified (Lower et al., 2002). The clinical history and physical findings in the affected males indicated that the phenotype is milder and more variable than previously described and evolves with age. Generally, in the first year, the babies are floppy, with failure to thrive, big ears, and small external genitalia. As schoolboys, the picture is one of learning problems and moderate short stature, with emerging truncal obesity and gynecomastia. Head circumferences are usually normal, and macrocephaly may be seen. Big ears and small genitalia remain. The toes are short and fingers tapered and malleable. In late adolescence and adult life, the classically described heavy facial appearance emerges. Some heterozygous females showed milder clinical features such as tapering fingers and shortened toes. Significant learning problems were found in 20%, and skewed X inactivation in 95%. Turner et al. (2004) concluded that the syndrome may be underdiagnosed in males in their early years and missed altogether in isolated heterozygous females.

Manifestations in Females

Dereymaeker et al. (1986) described a typical case. The mother had suggestive features, and a first cousin, the daughter of a maternal male (who was himself 'feeble-minded,' but with a normal somatic phenotype), had hyperkyphosis that increased with age, no menarche at age 17, and sudden death at age 17 due probably to epileptic seizures.

Using a methylation-specific PCR assay, Kubota et al. (1999) demonstrated that a woman with typical findings of the BFL syndrome had an extremely skewed X-inactivation pattern. The 32-year-old Japanese woman was the only affected member of her family. She was hypotonic during early infancy and attended a school for the mentally handicapped. She had the first seizure at age 3 and became obese at age 5. Diabetic ketoacidosis crisis occurred at age 31 years. Her height was only 142 cm. She had a 'coarse' face with a narrow forehead, prominent supraorbital ridges, narrow palpebral fissures, ptosis, deep-set eyes, full cheeks, and large ears. Her hands were small with tapering fingers and short fifth fingers.

In all but 1 of the female carriers tested by Lower et al. (2002), the chromosome carrying the mutation in PHF6 (300414; see later) was 100% inactivated. The exception was a woman with roughly 70% skewing, who showed mild clinical features of BFLS, including obesity, large ears, amenorrhea, hypothyroidism, epilepsy, and learning difficulties.

Crawford et al. (2006) reported a 14-year-old girl with BFLS-like symptoms, with psychomotor retardation, IQ of 84 at age 4, and a remarkably shallow forehead, large ears with fleshy earlobes, deep-set eyes with a wide neck and face, broad feet, and hammertoes. Testing of her blood DNA showed a 93% skewed X-inactivation pattern.

Wieczorek et al. (2013) reported 2 females described as having Coffin-Siris syndrome (CSS; 135900) with mutations in the PHF6 gene. The first girl presented with mild to moderate developmental delay, hypertrichosis, coarse facial features, hypoplastic fifth finger- and toenails, and hypoplastic fifth digits. These features fulfilled the diagnostic criteria for CSS; Wieczorek et al. (2013) remarked that more characteristic clinical features of BFLS may not be evident in early childhood. A second girl was found to have a de novo frameshift mutation in PHF6. She had mild intellectual disability, average stature, and hypoplasia of distal phalanges of the fifth digits. Additionally, she had nystagmus, strabismus, and coarse facial features.


Mapping

In a family with presumed BFL syndrome, Mulley et al. (1989) found suggestions of linkage to X DNA markers that would place the locus in the Xq26-q27 region. On the basis of the same study, Turner et al. (1989) reported a maximum lod score of 2.1 at theta = 0.0 with DXS51. The regional localization was thought to be Xq26-q27. The 7 affected males showed mild to moderate intellectual handicap, remarkably long, thick ears, deep-set eyes, small testes, and postpubertal gynecomastia. The affected males and some of the heterozygous females also had tapering fingers and short, widely spaced and flexed toes. Mathews et al. (1989) also found evidence suggesting location of the BFLS locus on distal Xq. They found maximum lod scores of 2.32 with DXS10 and 2.24 with DXS51, both at theta = 0.0. Mathews et al. (1989) combined the 2 sets of data and arrived at a maximum lod score of 4.09. The family studied by Mathews et al. (1989) was one of those reported by Ardinger et al. (1984). The clinical features as demonstrated by the photographs were strikingly similar to those in the family of Turner et al. (1989).


Molecular Genetics

Lower et al. (2002) narrowed the interval of the BFLS locus to roughly 9 Mb containing more than 62 genes. Among these, a novel, widely expressed zinc finger gene, designated PHF6 (300414), had 8 missense and truncation mutations in 7 familial and 2 sporadic cases of BFLS. Transfection studies with PHF6 tagged with green fluorescent protein (GFP) showed diffuse nuclear staining with prominent nucleolar accumulation. Such localization, and the presence of 2 plant homeodomain (PHD)-like zinc fingers, suggested a role for PHF6 in transcription.

Lower et al. (2004) identified a mutation in the PHF6 gene (300414.0001) in affected members of the original BFLS family reported by Borjeson et al. (1962) and in affected members of a previously undescribed BFLS family from Western Australia.

In a 14-year-old girl with BFLS-like symptoms, Crawford et al. (2006) identified heterozygosity for a 1-bp insertion in the PHF6 gene (300414.0010). The authors stated that this was the first report of a clinically diagnosed BFLS female with a confirmed PHF6 mutation. Crawford et al. (2006) also identified mutations in the PHF6 gene in 4 of 24 unrelated males with clinically diagnosed BFLS; 1 was an isolated case with skewed maternal X inactivation, and 3 were familial cases, of which 2 had skewed maternal X inactivation. Crawford et al. (2006) concluded that the success of PHF6 screening in males suspected of having BFLS is markedly increased if there is a positive family history and/or skewed X inactivation is found in the mother.

Gecz et al. (2006) reviewed the clinical features and molecular genetics of BFLS, stating that 19 unrelated mutation-positive cases had been reported, of which 13 were familial and 6 were isolated cases.

Wieczorek et al. (2013) reported 2 females, each with a de novo mutation in the PHF6 gene (e.g., C305F; 300414.0011), who fulfilled diagnostic criteria for Coffin-Siris syndrome (CSS; 135900).


History

Gecz et al. (1999) identified a male infant with BFLS-like features and a duplication, 46,Y,dup(X)(q26q28), inherited from his phenotypically normal mother. FISH using yeast artificial chromosome clones from Xq26 localized the duplication breakpoint to an interval of approximately 400 kb in the Xq26.3 region between DXS155 and DXS294/DXS730. Database searches and analysis of available genomic DNA sequence from the region revealed the presence of the fibroblast growth factor-13 gene (FGF13; 300070) within the duplication breakpoint interval. Northern blot hybridization showed highest expression of FGF13 in brain and skeletal muscle. The FGF13 gene localization and tissue-specific expression pattern suggested that it is a candidate gene for familial cases of BFLS and other syndromal and nonspecific forms of X-linked mental retardation mapping to that region.


See Also:

Flannery et al. (1985); Mathews et al. (1989)

REFERENCES

  1. Ardinger, H. H., Hanson, J. W., Zellweger, H. U. Borjeson-Forssman-Lehmann syndrome: further delineation in five cases. Am. J. Med. Genet. 19: 653-664, 1984. [PubMed: 6517094] [Full Text: https://doi.org/10.1002/ajmg.1320190405]

  2. Baar, H. S., Galindo, J. The Borjeson-Forssman-Lehmann syndrome. J. Ment. Defic. Res. 9: 125-130, 1965. [PubMed: 14323171] [Full Text: https://doi.org/10.1111/j.1365-2788.1965.tb00829.x]

  3. Borjeson, M., Forssman, H., Lehmann, O. An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med. Scand. 171: 13-21, 1962. [PubMed: 13871358] [Full Text: https://doi.org/10.1111/j.0954-6820.1962.tb04162.x]

  4. Brun, A., Borjeson, M., Forssman, H. An inherited syndrome with mental deficiency and endocrine disorder: a patho-anatomical study. J. Ment. Defic. Res. 18: 317-325, 1974. [PubMed: 4465467] [Full Text: https://doi.org/10.1111/j.1365-2788.1974.tb01243.x]

  5. Crawford, J., Lower, K. M., Hennekam, R. C. M., Van Esch, H., Megarbane, A., Lynch, S. A., Turner, G., Gecz, J. Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J. Med. Genet. 43: 238-243, 2006. [PubMed: 15994862] [Full Text: https://doi.org/10.1136/jmg.2005.033084]

  6. Dereymaeker, A. M., Fryns, J. P., Hoefnagels, M., Heremans, G., Marien, J., van den Berghe, H. The Borjeson-Forssman-Lehmann syndrome: a family study. Clin. Genet. 29: 317-320, 1986. [PubMed: 3720009]

  7. Flannery, D. B., Piussan, C., Wright, L. E. Dermatoglyphics in Borjeson-Forssman-Lehmann syndrome. (Letter) Am. J. Med. Genet. 21: 401-404, 1985. [PubMed: 4014320] [Full Text: https://doi.org/10.1002/ajmg.1320210223]

  8. Gecz, J., Baker, E., Donnelly, A., Ming, J. E., McDonald-McGinn, D. M., Spinner, N. B., Zackai, E. H., Sutherland, G. R., Mulley, J. C. Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum. Genet. 104: 56-63, 1999. [PubMed: 10071193] [Full Text: https://doi.org/10.1007/s004390050910]

  9. Gecz, J., Turner, G., Nelson, J., Partington, M. The Borjeson-Forssman-Lehman (sic) syndrome (BFLS, MIM #301900). Europ. J. Hum. Genet. 14: 1233-1237, 2006. [PubMed: 16912705] [Full Text: https://doi.org/10.1038/sj.ejhg.5201639]

  10. Kubota, T., Oga, S., Ohashi, H., Iwamoto, Y., Fukushima, Y. Borjeson-Forssman-Lehmann syndrome in a woman with skewed X-chromosome inactivation. Am. J. Med. Genet. 87: 258-261, 1999. [PubMed: 10564881]

  11. Lower, K. M., Solders, G., Bondeson, M.-L., Nelson, J., Brun, A., Crawford, J., Malm, G., Borjeson, M., Turner, G., Partington, M., Gecz, J. 1024C-T (R342X) is a recurrent PHF6 mutation also found in the original Borjeson-Forssman-Lehmann syndrome family. (Letter) Europ. J. Hum. Genet. 12: 787-789, 2004. [PubMed: 15241480] [Full Text: https://doi.org/10.1038/sj.ejhg.5201228]

  12. Lower, K. M., Turner, G., Kerr, B. A., Mathews, K. D., Shaw, M. A., Gedeon, A. K., Schelley, S., Hoyme, H. E., White, S. M., Delatycki, M. B., Lampe, A. K., Clayton-Smith, J., and 9 others. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nature Genet. 32: 661-665, 2002. [PubMed: 12415272] [Full Text: https://doi.org/10.1038/ng1040]

  13. Mathews, K. D., Ardinger, H. H., Nishimura, D. Y., Buetow, K. H., Murray, J. C., Bartley, J. A. Linkage localization of Borjeson-Forssman-Lehmann syndrome. Am. J. Med. Genet. 34: 470-474, 1989. [PubMed: 2624254] [Full Text: https://doi.org/10.1002/ajmg.1320340403]

  14. Mathews, K. D., Buetow, K., Turner, G., Mulley, J. Borjeson-Forssman-Lehmann syndrome localization. (Letter) Am. J. Med. Genet. 34: 475 only, 1989. [PubMed: 2491427] [Full Text: https://doi.org/10.1002/ajmg.1320340404]

  15. Mulley, J. C., Turner, G., Gedeon, A., Sutherland, G. R., Rae, J., Power, K., Arthur, I. Borjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. (Abstract) Cytogenet. Cell Genet. 51: 1049 only, 1989.

  16. Robinson, L. K., Jones, K. L., Culler, F., Nyhan, W. L., Sakati, N., Jones, K. L. The Borjeson-Forssman-Lehmann syndrome. Am. J. Med. Genet. 15: 457-468, 1983. [PubMed: 6683929] [Full Text: https://doi.org/10.1002/ajmg.1320150311]

  17. Turner, G., Gedeon, A., Mulley, J., Sutherland, G., Rae, J., Power, K., Arthur, I. Borjeson-Forssman-Lehmann syndrome: clinical manifestations and gene localization to Xq26-27. Am. J. Med. Genet. 34: 463-469, 1989. [PubMed: 2624253] [Full Text: https://doi.org/10.1002/ajmg.1320340402]

  18. Turner, G., Lower, K. M., White, S. M., Delatycki, M., Lampe, A. K., Wright, M., Clayton-Smith, J., Kerr, B., Schelley, S., Hoyme, H. E., De Vries, B. B. A., Kleefstra, T., Grompe, M., Cox, B., Gecz, J., Partington, M. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin. Genet. 65: 226-232, 2004. [PubMed: 14756673] [Full Text: https://doi.org/10.1111/j.0009-9163.2004.00215.x]

  19. Weber, F. T., Frias, J. L., Julius, R. L., Felman, A. H. Primary hypogonadism in the Borjeson-Forssman-Lehmann syndrome. J. Med. Genet. 15: 63-66, 1978. [PubMed: 564968] [Full Text: https://doi.org/10.1136/jmg.15.1.63]

  20. Wieczorek, D., Bogershausen, N., Beleggia, F., Steiner-Haldenstatt, S., Pohl, E., Li, Y., Milz, E., Martin, M., Thiele, H., Altmuller, J., Alanay, Y., Kayserili, H., and 44 others. A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum. Molec. Genet. 22: 5121-5135, 2013. [PubMed: 23906836] [Full Text: https://doi.org/10.1093/hmg/ddt366]


Contributors:
Ada Hamosh - updated : 06/27/2014
Marla J. F. O'Neill - updated : 3/2/2007
Marla J. F. O'Neill - updated : 4/19/2006
Marla J. F. O'Neill - updated : 11/5/2004
Victor A. McKusick - updated : 2/25/2004
Victor A. McKusick - updated : 11/4/2002
Victor A. McKusick - updated : 12/6/1999
Victor A. McKusick - updated : 3/16/1999

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
carol : 03/01/2021
carol : 02/18/2021
carol : 03/12/2020
alopez : 06/27/2014
carol : 10/26/2011
ckniffin : 10/25/2011
wwang : 3/6/2007
terry : 3/2/2007
wwang : 4/20/2006
terry : 4/19/2006
tkritzer : 11/5/2004
tkritzer : 3/1/2004
terry : 2/25/2004
alopez : 12/3/2002
alopez : 11/5/2002
terry : 11/4/2002
carol : 12/22/1999
carol : 12/8/1999
terry : 12/6/1999
terry : 5/20/1999
carol : 3/17/1999
terry : 3/16/1999
mimadm : 2/27/1994
carol : 2/25/1994
supermim : 3/17/1992
supermim : 3/20/1990
supermim : 2/6/1990
carol : 12/14/1989